Innovation and Sanger's Researchers
The Sanger Institute has always sought to facilitate improvements in human health. As the Institute continues to generate an ever deeper biological understanding of the genomic data and engender clinical perspectives to its science it will be faced with even greater opportunities to contribute to healthcare improvements.
Our Translation Team is comprised of former researchers with expertise in all aspects of technology identification, assessment, protection, development and commercialisation. We will help you translate your research towards a product or service that enables healthcare benefit by:
- Conducting thorough technology evaluations and market research
- Protecting your idea through filing a patent if appropriate
- Assisting with development plans and funding
- Undertaking extensive business development activities
- Structuring and negotiating collaboration, evaluation, license and spin-out agreements
- Managing established development partnerships
Adrian joined the Sanger Institute in 2011 to establish the Translation Office. With a background spanning academic research, structured finance and technology protection, development and commercialisation, Adrian was recruited to optimise the ability of Sanger Institute science to provide healthcare benefit. The first quinquennium of technology translation at Sanger has seen significant expansion and maturation of the Sanger Institute's portfolio of spin-out companies, the establishment of the 50 FTE Centre for Therapeutic Target Validation and execution of licensing deals with major strategic benefits for the exploitation of key Institute assets.
Podcast with Dr Adrian Ibrahim & CUTEC
Find out about what science translation means and how the Wellcome Sanger Institute's Technology Transfer Office is making a difference to so many areas of healthcare- from developing new cancer medicines to global tracking of malaria to help prevent its spread.